[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  PharmaShots - Incisive news in X shots [@Pharmashot](/creator/twitter/Pharmashot) on x 2266 followers Created: 2025-06-27 07:03:59 UTC Pfizer Reports the P-III (BASIS) Study Data Evaluating HYMPAVZI to Treat Hemophilia A or B with Inhibitors #galderma #nemolizumab #systemicsclerosis #chronicpruritusofunknownorigin #il31 #monoclonalantibody #atopicdermatitis #prurigonodularis #phaseii  XX engagements  **Related Topics** [$galdsw](/topic/$galdsw) [$pfe](/topic/$pfe) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/Pharmashot/status/1938493497432281437)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PharmaShots - Incisive news in X shots @Pharmashot on x 2266 followers
Created: 2025-06-27 07:03:59 UTC
Pfizer Reports the P-III (BASIS) Study Data Evaluating HYMPAVZI to Treat Hemophilia A or B with Inhibitors #galderma #nemolizumab #systemicsclerosis #chronicpruritusofunknownorigin #il31 #monoclonalantibody #atopicdermatitis #prurigonodularis #phaseii
XX engagements
Related Topics $galdsw $pfe stocks healthcare
/post/tweet::1938493497432281437